Thomas J. Perun

2.3k total citations
48 papers, 1.4k citations indexed

About

Thomas J. Perun is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Thomas J. Perun has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 20 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Thomas J. Perun's work include Carbohydrate Chemistry and Synthesis (12 papers), Microbial Natural Products and Biosynthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Thomas J. Perun is often cited by papers focused on Carbohydrate Chemistry and Synthesis (12 papers), Microbial Natural Products and Biosynthesis (8 papers) and Chemical Synthesis and Analysis (7 papers). Thomas J. Perun collaborates with scholars based in United States, United Kingdom and Sweden. Thomas J. Perun's co-authors include Richard S. Egan, Jerry R. Martin, Paul Kurath, Herman H. Stein, Jacob J. Plattner, Jerome Cohen, Jay R. Luly, Ryuichi Sakai, David S. Seigler and Lois S. Shield and has published in prestigious journals such as Journal of the American Chemical Society, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas J. Perun

48 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thomas J. Perun 678 612 222 133 114 48 1.4k
Bertrand Castro 1.7k 2.5× 1.1k 1.7× 187 0.8× 177 1.3× 54 0.5× 76 2.5k
M. Soriano-Garcı́a 778 1.1× 384 0.6× 80 0.4× 84 0.6× 103 0.9× 176 1.8k
Simon F. Campbell 833 1.2× 791 1.3× 124 0.6× 166 1.2× 69 0.6× 54 1.9k
Bhabatarak Bhattacharyya 1.2k 1.8× 673 1.1× 108 0.5× 56 0.4× 73 0.6× 57 2.0k
Yutaka Aoyagi 808 1.2× 984 1.6× 134 0.6× 66 0.5× 45 0.4× 96 2.1k
Suvit Thaisrivongs 999 1.5× 1.4k 2.3× 238 1.1× 119 0.9× 21 0.2× 55 2.6k
Dee W. Brooks 737 1.1× 974 1.6× 338 1.5× 132 1.0× 191 1.7× 56 2.0k
Takumi Watanabe 615 0.9× 852 1.4× 129 0.6× 62 0.5× 85 0.7× 82 1.5k
V. P. MARSHALL 695 1.0× 232 0.4× 224 1.0× 80 0.6× 28 0.2× 56 1.2k
Markus Voehler 904 1.3× 271 0.4× 138 0.6× 111 0.8× 59 0.5× 55 1.5k

Countries citing papers authored by Thomas J. Perun

Since Specialization
Citations

This map shows the geographic impact of Thomas J. Perun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Perun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Perun more than expected).

Fields of papers citing papers by Thomas J. Perun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Perun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Perun. The network helps show where Thomas J. Perun may publish in the future.

Co-authorship network of co-authors of Thomas J. Perun

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Perun. A scholar is included among the top collaborators of Thomas J. Perun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Perun. Thomas J. Perun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perun, Thomas J.. (2016). Chemistry and Human Health. Chemistry International. 38(3-4). 42–44. 1 indexed citations
2.
Peake, David A., Douglas C. Duckworth, Thomas J. Perun, et al.. (2005). Analytical and Biological Evaluation of High Throughput Screen Actives Using Evaporative Light Scattering, Chemiluminescent Nitrogen Detection, and Accurate Mass LC-MS-MS. Combinatorial Chemistry & High Throughput Screening. 8(6). 477–487. 7 indexed citations
3.
Kulanthaivel, Palaniappan, et al.. (1999). Novel Naphthoquinones from a Streptomyces sp.. The Journal of Antibiotics. 52(3). 256–262. 13 indexed citations
4.
Stine, W. Blaine, Seth W. Snyder, Uri S. Ladror, et al.. (1996). The nanometer-scale structure of amyloid-Β visualized by atomic force microscopy. Journal of Protein Chemistry. 15(2). 193–203. 139 indexed citations
5.
Lartey, Paul A. & Thomas J. Perun. (1993). ChemInform Abstract: Synthetic Modifications of the Erythromycin A Macrolactone: Effects on Biological Activity. ChemInform. 24(33). 1 indexed citations
6.
Smitka, Tim A., et al.. (1992). A83016F, a new member of the aurodox family.. The Journal of Antibiotics. 45(4). 433–443. 6 indexed citations
7.
Dellaria, Joseph F., Robert G. Maki, Herman H. Stein, et al.. (1990). New inhibitors of renin that contain novel phosphostatine Leu-Val replacements. Journal of Medicinal Chemistry. 33(2). 534–542. 96 indexed citations
8.
Rinehart, Kenneth L., Tom G. Holt, Nancy L. Fregeau, et al.. (1990). Bioactive Compounds from Aquatic and Terrestrial Sources. Journal of Natural Products. 53(4). 771–792. 98 indexed citations
9.
Perun, Thomas J., et al.. (1989). Computer-Aided Drug Design: Methods and Applications. 40 indexed citations
10.
De, Biswanath, et al.. (1989). LH-RH antagonists: design and synthesis of a novel series of peptidomimetics. Journal of Medicinal Chemistry. 32(9). 2036–2038. 26 indexed citations
11.
Kleinert, Hollis D., Jay R. Luly, Patrick A. Marcotte, et al.. (1988). Renin inhibitors Improvements in the stability and biological activity of small peptides containing novel Leu‐Val replacements. FEBS Letters. 230(1-2). 38–42. 17 indexed citations
12.
Luly, Jay R., Giorgio Bolis, Nwe Y. BaMaung, et al.. (1988). New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site. Journal of Medicinal Chemistry. 31(3). 532–539. 19 indexed citations
13.
Bolis, Giorgio, Anthony K. L. Fung, Jonathan Greer, et al.. (1987). Renin inhibitors. Dipeptide analogs of angiotensinogen incorporating transition-state, nonpeptidic replacements at the scissile bond. Journal of Medicinal Chemistry. 30(10). 1729–1737. 24 indexed citations
14.
Pike, Victor W., Andrew Palmer, Peter Horlock, et al.. (1982). Preparation of a carbon-11 labelled antibiotic, erythromycin A lactobionate. Journal of the Chemical Society Chemical Communications. 173–173. 9 indexed citations
15.
Egan, Richard S., Jerry R. Martin, Thomas J. Perun, & Lester A. Mitscher. (1975). Conformational flexibility of erythronolide B, the 14-membered aglycon ring of the erythromycins. Journal of the American Chemical Society. 97(16). 4578–4583. 19 indexed citations
16.
Egan, Richard S., et al.. (1973). Conformational studies on chloramphenicol and related molecules. Tetrahedron. 29(14). 1961–1967. 8 indexed citations
17.
Perun, Thomas J. & Richard S. Egan. (1969). The conformation of erythromycin aglycones. Tetrahedron Letters. 10(5). 387–390. 19 indexed citations
18.
Mitscher, Lester A., et al.. (1969). The conformation of macrolide antibiotics. III. Circular dichroism and the conformation of erythromycins. Tetrahedron Letters. 10(52). 4505–4508. 9 indexed citations
19.
Perun, Thomas J., Richard S. Egan, & Jerry R. Martin. (1969). The conformation of macrolide antibiotics II. Configurational and conformational studies of dihydroerythronolides. Tetrahedron Letters. 10(52). 4501–4504. 15 indexed citations
20.
Martin, Jerry R. & Thomas J. Perun. (1968). Biosynthesis of the erythromycins. III. Isolation and structure of 5-deoxy-5-oxoerythronolide B, a shunt metabolite of erythromycin biosynthesis. Biochemistry. 7(5). 1728–1733. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026